Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database
Khalidah A. Alenzi, Deemah S. Alsuhaibani, Bader Batarfi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9

Showing 9 citing articles:

Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis
Ronghui Li, Panpan Luo, Yuge Guo, et al.
Expert Opinion on Drug Safety (2024), pp. 1-5
Closed Access | Times Cited: 9
Dose-dependent pancreatitis risk associated with GLP-1 agonists
Joyce H Gu, Mark Samarneh
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access | Times Cited: 1
Diabetic Ketoacidosis and the Use of New Hypoglycemic Groups: Real-World Evidence Utilizing the Food and Drug Administration Adverse Event Reporting System
Hilal Thaibah, Otilia J.F. Banji, David Banji, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 214-214
Open Access
Adverse Events Associated with Inclisiran: A Real-world pharmacovigilance study of FDA adverse event reporting system (FAERS)
Bing Li, Yan Chen, Y. Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Adverse drug reaction patterns of GLP‐1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database
Tae Hyeon Kim, Kyeongmin Lee, Seoyoung Park, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Evaluation of dipeptidyl peptidase-4 inhibitor-associated gastrointestinal symptoms using the prescription claims database
Ayana Funabashi, Hitoshi Ito, Mamoru Maeda, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration
Jing Zhang, Wang Xiao-fen, Yiting Zhou
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Joyce H Gu, Zachary Sheingold, Mark Samarneh
Cureus (2024)
Open Access | Times Cited: 1
Does Incretin Agonism Have Sustainable Efficacy?
Sok‐Ja Janket, Miyo K. Chatanaka, Dorsa Sohaei, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1842-1842
Open Access | Times Cited: 1
Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system
Yanjun Lu, Qian Xu, Sixi Zhu
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top